MWA
TECH icon

Medallion Wealth Advisors’s Bio-Techne TECH Stock Holding History

Medallion Wealth Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.7K Hold
1,200
– – 0.02% 431
2025
Q4 		$70.6K Hold
1,200
– – 0.02% 414
2025
Q3 		$66.8K Hold
1,200
– – 0.02% 421
2025
Q2 		$62.5K Hold
1,200
– – 0.02% 422
2025
Q1 		$68.8K Sell
1,200
-397
-25% -$26.9K 0.03% 369
2024
Q4 		$115K Buy
+1,597
New +$117K 0.06% 269

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Medallion Wealth Advisors's TECH Position: Q1 2026 in Review

Medallion Wealth Advisors held its Bio-Techne (TECH) position steady in Q1 2026 at 1,200 shares worth $62.7K. The position accounts for 0.02% of the portfolio, ranked #431.

Medallion Wealth Advisors first reported a position in TECH in Q4 2024 and has held it in 6 quarters since. The position peaked at $115K in Q4 2024. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Medallion Wealth Advisors held 1,200 shares of Bio-Techne worth $62.7K as of Q1 2026.
  • Medallion Wealth Advisors left its Bio-Techne share count unchanged in Q1 2026.
  • Bio-Techne made up 0.02% of Medallion Wealth Advisors's portfolio in Q1 2026, its #431 holding.
  • Medallion Wealth Advisors first reported a position in Bio-Techne in Q4 2024 and has held it in 6 quarters since.
  • Medallion Wealth Advisors's Bio-Techne position peaked at $115K in Q4 2024.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.